| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 7 351-357, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
GP Yang and LF Lau
Department of Genetics, University of Illinois College of Medicine, Chicago 60612.
cyr61 is a specific target for activation by platelet-derived growth factor and fibroblast growth factor and is inducible by the oncogene v-src. It is a member of the class of immediate early genes that includes those encoding protooncogene products, transcription factors, and cytokines. We have previously characterized the synthesis and degradation of the cyr61-encoded mRNA and protein. Although the deduced Cyr61 protein sequence contains an NH2-terminal secretory signal, it is not detectable in the conditioned medium of serum-stimulated cells. We show here that in rapidly growing cell cultures, newly synthesized Cyr61 is secreted and is associated with both the extracellular matrix and the cell surface. In contrast, Cyr61 secreted in serum-stimulated quiescent cells is directed to the cell surface and is hot incorporated into the extracellular matrix. Once associated with the extracellular matrix, Cyr61 has a half-life of greater than 24 h, whereas intracellular and cell surface-associated Cyr61 has an apparent half-life of approximately 30 min. Furthermore, Cyr61 appears to bind heparin with high affinity. These observations suggest similarities among Cyr61, the fibroblast growth factors (heparin-binding growth factors), and the protooncogene product Int-1 and are consistent with the hypothesis that Cyr61 plays a role in cell-cell communication involving the interaction of neighboring cells.
This article has been cited by other articles:
![]() |
M.-T. Lin, I-H. Kuo, C.-C. Chang, C.-Y. Chu, H.-Y. Chen, B.-R. Lin, M. Sureshbabu, H.-J. Shih, and M.-L. Kuo Involvement of Hypoxia-inducing Factor-1{alpha}-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion J. Biol. Chem., June 6, 2008; 283(23): 15807 - 15815. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gashaw, S. Stiller, C. Boing, R. Kimmig, and E. Winterhager Premenstrual Regulation of the Pro-Angiogenic Factor CYR61 in Human Endometrium Endocrinology, May 1, 2008; 149(5): 2261 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sawai, M. Mukoyama, K. Mori, M. Kasahara, M. Koshikawa, H. Yokoi, T. Yoshioka, Y. Ogawa, A. Sugawara, H. Nishiyama, et al. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1363 - F1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Athanasopoulos, D. Schneider, T. Keiper, V. Alt, U. R. Pendurthi, U. M. Liegibel, U. Sommer, P. P. Nawroth, C. Kasperk, and T. Chavakis Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing J. Biol. Chem., September 14, 2007; 282(37): 26746 - 26753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nguyen, A. Kuliopulos, R. A. Graham, and L. Covic Tumor-Derived Cyr61(CCN1) Promotes Stromal Matrix Metalloproteinase-1 Production and Protease-Activated Receptor 1-Dependent Migration of Breast Cancer Cells. Cancer Res., March 1, 2006; 66(5): 2658 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chen, S.-J. Leu, V. Todorovic, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells J. Biol. Chem., October 15, 2004; 279(42): 44166 - 44176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Leu, N. Chen, C.-C. Chen, V. Todorovic, T. Bai, V. Juric, Y. Liu, G. Yan, S. C.-T. Lam, and L. F. Lau Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61): SELECTIVE INACTIVATION OF INTEGRIN {alpha}6{beta}1-HEPARAN SULFATE PROTEOGLYCAN CORECEPTOR-MEDIATED CELLULAR FUNCTIONS J. Biol. Chem., October 15, 2004; 279(42): 44177 - 44187. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Leu, Y. Liu, N. Chen, C.-C. Chen, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}6{beta}1 Binding Site in the Angiogenic Inducer CCN1 (CYR61) J. Biol. Chem., September 5, 2003; 278(36): 33801 - 33808. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Latinkic, S. Mercurio, B. Bennett, E. M. A. Hirst, Q. Xu, L. F. Lau, T. J. Mohun, and J. C. Smith Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling Development, June 1, 2003; 130(11): 2429 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Kim, Y. K. Min, J.-H. Baik, L. F. Lau, B. Chaqour, and K. C. Chung Expression of Angiogenic Factor Cyr61 during Neuronal Cell Death via the Activation of c-Jun N-terminal Kinase and Serum Response Factor J. Biol. Chem., April 11, 2003; 278(16): 13847 - 13854. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-E Mo, A. G. Muntean, C.-C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau CYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity Mol. Cell. Biol., December 15, 2002; 22(24): 8709 - 8720. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Walker, P. R. van Ginkel, R. L. Gee, H. Ahmadi, L. Subramanian, B. R. Ksander, L. F. Meisner, D. M. Albert, and A. S. Polans Expression of Angiogenic Factors Cyr61 and Tissue Factor in Uveal Melanoma Arch Ophthalmol, December 1, 2002; 120(12): 1719 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Leu, S. C.-T. Lam, and L. F. Lau Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins alpha vbeta 3 and alpha 6beta 1 in Human Umbilical Vein Endothelial Cells J. Biol. Chem., November 22, 2002; 277(48): 46248 - 46255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hilfiker, D. Hilfiker-Kleiner, M. Fuchs, K. Kaminski, A. Lichtenberg, H.-J. Rothkotter, B. Schieffer, and H. Drexler Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II Circulation, July 9, 2002; 106(2): 254 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schober, N. Chen, T. M. Grzeszkiewicz, I. Jovanovic, E. E. Emeson, T. P. Ugarova, R. D. Ye, L. F. Lau, and S. C.-T. Lam Identification of integrin alpha Mbeta 2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions Blood, May 29, 2002; 99(12): 4457 - 4465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Grzeszkiewicz, V. Lindner, N. Chen, S. C.-T. Lam, and L. F. Lau The Angiogenic Factor Cysteine-Rich 61 (CYR61, CCN1) Supports Vascular Smooth Muscle Cell Adhesion and Stimulates Chemotaxis through Integrin {alpha}6{beta}1 and Cell Surface Heparan Sulfate Proteoglycans Endocrinology, April 1, 2002; 143(4): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chen, F.-E Mo, and L. F. Lau The Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts J. Biol. Chem., December 7, 2001; 276(50): 47329 - 47337. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Desnoyers, D. Arnott, and D. Pennica WISP-1 Binds to Decorin and Biglycan J. Biol. Chem., December 7, 2001; 276(50): 47599 - 47607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Maillard, B Cadot, R Y Ball, K Sethia, D R Edwards, B Perbal, and R Tatoud Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol. Pathol., August 1, 2001; 54(4): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sampath, R. C. Winneker, and Z. Zhang Cyr61, a Member of the CCN Family, Is Required for MCF-7 Cell Proliferation: Regulation by 17{beta}-Estradiol and Overexpression in Human Breast Cancer Endocrinology, June 1, 2001; 142(6): 2540 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Latinkic, F.-E Mo, J. A. Greenspan, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, S. R. Ross, and L. F. Lau Promoter Function of the Angiogenic Inducer Cyr61Gene in Transgenic Mice: Tissue Specificity, Inducibility During Wound Healing, and Role of the Serum Response Element Endocrinology, June 1, 2001; 142(6): 2549 - 2557. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Perbal NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues Mol. Pathol., April 1, 2001; 54(2): 57 - 79. [Abstract] [Full Text] |
||||
![]() |
G. R. Grotendorst, L. F. Lau, and B. Perbal CCN Proteins Are Distinct from, and Should Not Be Considered Members of, the Insulin-Like Growth Factor-Binding Protein Superfamily J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 944 - 945. [Full Text] |
||||
![]() |
M.-S. Tsai, A. E. Hornby, J. Lakins, and R. Lupu Expression and Function of CYR61, an Angiogenic Factor, in Breast Cancer Cell Lines and Tumor Biopsies Cancer Res., October 1, 2000; 60(20): 5603 - 5607. [Abstract] [Full Text] |
||||
![]() |
G. R. Grotendorst, L. F. Lau, and B. Perbal CCN Proteins Are Distinct from and Should Not Be Considered Members of the Insulin-Like Growth Factor-Binding Protein Superfamily Endocrinology, June 1, 2000; 141(6): 2254 - 2256. [Full Text] [PDF] |
||||
![]() |
U. R. Pendurthi, K. E. Allen, M. Ezban, and L. V. M. Rao Factor VIIa and Thrombin Induce the Expression of Cyr61 and Connective Tissue Growth Factor, Extracellular Matrix Signaling Proteins That Could Act as Possible Downstream Mediators in Factor VIIa{middle dot}Tissue Factor-induced Signal Transduction J. Biol. Chem., May 5, 2000; 275(19): 14632 - 14641. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hishikawa, B. S. Oemar, F. C. Tanner, T. Nakaki, T. F. Luscher, and T. Fujii Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7 J. Biol. Chem., December 24, 1999; 274(52): 37461 - 37466. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
![]() |
A. Jedsadayanmata, C.-C. Chen, M. L. Kireeva, L. F. Lau, and S. C.-T. Lam Activation-dependent Adhesion of Human Platelets to Cyr61 and Fisp12/Mouse Connective Tissue Growth Factor Is Mediated through Integrin alpha IIbbeta 3 J. Biol. Chem., August 20, 1999; 274(34): 24321 - 24327. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Brigstock The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family Endocr. Rev., April 1, 1999; 20(2): 189 - 206. [Abstract] [Full Text] |
||||
![]() |
Christine P. Burren, E. M. Wilson, V. Hwa, Y. Oh, and R. G. Rosenfeld Binding Properties and Distribution of Insulin-Like Growth Factor Binding Protein-Related Protein 3 (IGFBP-rP3/NovH), an Additional Member of the IGFBP Superfamily J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1096 - 1103. [Abstract] [Full Text] |
||||
![]() |
K. Kuno and K. Matsushima ADAMTS-1 Protein Anchors at the Extracellular Matrix through the Thrombospondin Type I Motifs and Its Spacing Region J. Biol. Chem., May 29, 1998; 273(22): 13912 - 13917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Babic, M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth PNAS, May 26, 1998; 95(11): 6355 - 6360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Kireeva, S. C.-T. Lam, and L. F. Lau Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin alpha vbeta 3 J. Biol. Chem., January 30, 1998; 273(5): 3090 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Kim, S. R. Nagalla, Y. Oh, E. Wilson, C. T. Roberts Jr., and R. G. Rosenfeld Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily PNAS, November 25, 1997; 94(24): 12981 - 12986. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Brigstock, C. L. Steffen, G. Y. Kim, R. K. Vegunta, J. R. Diehl, and P. A. Harding Purification and Characterization of Novel Heparin-binding Growth Factors in Uterine Secretory Fluids. IDENTIFICATION AS HEPARIN-REGULATED Mr 10,000 FORMS OF CONNECTIVE TISSUE GROWTH FACTOR J. Biol. Chem., August 8, 1997; 272(32): 20275 - 20282. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Oemar and T. F. Luscher Connective Tissue Growth Factor : Friend or Foe? Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1483 - 1489. [Abstract] [Full Text] |
||||
![]() |
M Wick, C Burger, S Brusselbach, F. Lucibello, and R Muller Identification of serum-inducible genes: different patterns of gene regulation during G0-->S and G1-->S progression J. Cell Sci., January 1, 1994; 107(1): 227 - 239. [Abstract] [PDF] |
||||
![]() |
N. Chen, C.-C. Chen, and L. F. Lau Adhesion of Human Skin Fibroblasts to Cyr61 Is Mediated through Integrin alpha 6beta 1 and Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., August 4, 2000; 275(32): 24953 - 24961. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Albrecht, H. von der Kammer, M. Mayhaus, J. Klaudiny, M. Schweizer, and R. M. Nitsch Muscarinic Acetylcholine Receptors Induce the Expression of the Immediate Early Growth Regulatory Gene CYR61 J. Biol. Chem., September 8, 2000; 275(37): 28929 - 28936. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chen, N. Chen, and L. F. Lau The Angiogenic Factors Cyr61 and Connective Tissue Growth Factor Induce Adhesive Signaling in Primary Human Skin Fibroblasts J. Biol. Chem., March 23, 2001; 276(13): 10443 - 10452. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Grzeszkiewicz, D. J. Kirschling, N. Chen, and L. F. Lau CYR61 Stimulates Human Skin Fibroblast Migration through Integrin alpha vbeta 5 and Enhances Mitogenesis through Integrin alpha vbeta 3, Independent of Its Carboxyl-terminal Domain J. Biol. Chem., June 8, 2001; 276(24): 21943 - 21950. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |